Earnings Scheduled For April 28, 2022 2022/04/28 08:50:40 Benzinga
Companies Reporting Before The Bell • PBF Energy (NYSE: PBF ) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. • Merck & Co (NYSE: MRK ) is estimated to report quarterly earnings at $1.83 per share on revenue of $14.68 billion. • Smith & Nephew (NYSE: SNN ) is estimated to report earnings for its first quarter. • Domino''s Pizza (NYSE: DPZ ) is estimated to report quarterly earnings at $3.05 per share on revenue of $1.03 billion. • Limelight Networks (NASDAQ: LLNW ) is projected to report quarterly loss at $0.04 per share on revenue of $56.30 million. • FTI Consulting (NYSE: FCN ) is expected to report quarterly earnings at $1.33 per share on revenue of $703.00 million. • T. Rowe Price Gr (NASDAQ: TROW ) is expected to report quarterly earnings at $2.74 per share on revenue of $1.89 billion. • Stericycle (NASDAQ: SRCL ) is likely to report quarterly earnings at $0.46 per share on revenue of $671.00 million. • Abiomed (NASDAQ: ABMD ) is estimated to report quarterly earnings at $1.
ABMD, ATRC stocks draw bullish views at Piper on proposed Medicare rates (NASDAQ:ABMD) 2022/04/19 18:55:51 Seeking Alpha
Abiomed (ABMD) and AtriCure (ATRC) were among some of the healthcare equipment makers to earn bullish views at Piper Sandler after the Centers for Medicare and Medicaid Services…
Medical-Device Stocks Surge Most Since 2020 After J&J Results - BNN Bloomberg 2022/04/19 16:51:34 BNN Bloomberg
Shares of Intuitive Surgical Inc., Abiomed Inc. and other medical-device makers rallied Tuesday after Johnson & Johnson reported stronger-than-expected sales from that division of the company.
Is Abiomed (ABMD) A Great Investment to Take? 2022/03/07 14:10:42 Insider Monkey
Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference | MarketScreener 2022/02/08 21:07:03 MarketScreener
Abiomed, Inc. , a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at… | February 8, 2022
Smallest Heart Pump From Abiomed Gets FDA Breakthrough Device Tag 2021/08/18 15:04:41 Benzinga
The FDA has granted breakthrough device designation to Abiomed Inc''s (NASDAQ: ABMD ) Impella ECP expandable percutaneous heart pump. Abiomed designed the Impella ECP heart pump to be compatible with small-bore Full story available on Benzinga.com
Verde Servicos Internacionais S.A. Buys Bank of America Corp, XP Inc, Alphabet Inc, Sells ... 2021/08/16 20:38:07 GuruFocus
Related Stocks: MDLZ , MELI , LOW , PYPL , BAC , XP , GOOG , DELL , NXPI , NOW , BRK.B , RSG , NKE , ABMD , BIDU , PLTR ,
Ownership Capital B.V. Buys Abiomed Inc, ResMed Inc, Maravai LifeSciences Holdings Inc, Sells ... 2021/08/11 06:38:03 GuruFocus
Related Stocks: RMD , ABMD , MRVI , DXCM , V ,
Abiomed Inc (ABMD) Chairman, President, CEO Michael R Minogue Sold $11 million of Shares 2021/08/11 06:15:03 GuruFocus
Related Stocks: ABMD ,
Is it the right time to invest in Abiomed (ABMD) stock? 2021/08/10 20:33:46 AlphaStreet
Medical devices like ventilators and personal protective equipment have been in high demand during the pandemic and their shortage often adds to the burden of the stressed healthcare system. But  The post Is it the right time to invest in Abiomed (ABMD) stock? first appeared on AlphaStreet .
Ventricular Assist Device Market 2021 Precise Outlook- Abiomed Inc., BiVACOR Inc, Abbott Laboratories 2021/07/15 07:15:06 OpenPR
The Ventricular Assist Device market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market
Companies Insight of LVAD Market 2021-2025 Featuring Abbott Laboratories, Abiomed Inc., and Berlin Heart GmbH | Technavio 2021/07/08 15:00:00 Benzinga
NEW YORK , July 8, 2021 /PRNewswire/ -- The LVAD market is expected to grow by USD 962.42 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the LVAD market in optimistic, probable, and pessimistic forecast scenarios. Enterprises will go through the Response, Recovery, and Renew phases. Download a Free Sample Report on COVID-19 The LVAD market will witness a positive impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio''s pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020. With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
Abiomed Inc (ABMD): Price Up $2.99 (0.96)% Over Past Day, Up $2.17 (0.69)% Over Past Hour 2021/06/29 15:14:26 ETF Daily News
Regarding the trend, note that the strongest trend exists on the 50 hour timeframe. The post Abiomed Inc (ABMD): Price Up $2.99 (0.96)% Over Past Day, Up $2.17 (0.69)% Over Past Hour appeared first on ETF Daily News .
Abiomed''s Impella RP With SmartAssist Gets FDA Pre-market Approval To Treat Right Heart Failure 2021/06/29 12:23:55 Business Insider Markets
(RTTNews) - Abiomed Inc. (ABMD), on Tuesday, announced that its newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration pre-market approval or PMA as safe and effective to treat acute right heart failure for up to 14 days. Impella RP with SmartAssist is the first single-access temporary